过表达MyBPC1对牛骨骼肌卫星细胞增殖分化的影响

旨在探究肌球蛋白结合蛋白C1（myosin binding protein C1,MyBPC1）对牛骨骼肌卫星细胞增殖与成肌分化的影响,为进一步研究MyBPC1在细胞分化和肌肉发育过程中的调控作用提供依据。本研究利用西门塔尔胎牛原代牛骨骼肌卫星细胞体外诱导成肌分化模型模拟牛骨骼肌的生长发育过程。采用qRT-PCR和Western blot检测MyBPC1的细胞时序表达谱。试验分为两组。在RNA水平每组4个重复,每个重复20 μL;在蛋白水平每组3个重复,每个重复15 μg。采用qRT-PCR和Western blot检测牛骨骼肌卫星细胞转染MyBPC1的过表达效果,并进一步检测细胞增殖期标志因子Pax7、Ki67以及细胞分化期标志因子MyHC、MyOG的表达变化情况,观察牛骨骼肌卫星细胞肌管形成状态。结果,MyBPC1在牛骨骼肌卫星细胞分化前后表达水平存在极显著差异,牛骨骼肌卫星细胞诱导分化后MyBPC1的mRNA和蛋白表达量均极显著高于增殖期（P<0.01）。过表达MyBPC1后,细胞分化形成的肌管数量明显多于对照组,增殖标志因子Pax7的mRNA水平和蛋白表达水平无显著差异,分化标志因子MyHC的mRNA水平和蛋白表达水平极显著高于对照组（P<0.01）。过表达MyBPC1可以促进牛骨骼肌卫星细胞体外成肌分化,为进一步开展MyBPC1对牛骨骼肌卫星细胞的调控机制奠定基础。     

日粮蛋白质水平对云南半细毛羊空怀母羊能量代谢的影响

为研究日粮蛋白质水平对云南半细毛羊空怀母羊能量代谢的影响,试验选择25只云南半细毛羊空怀母羊,平均分为5个组,分别饲喂蛋白质水平为8.4%、10.0%、12.3%、13.6%、15.9%的日粮,用全收粪法进行消化代谢试验,试验期共19 d,预试期14 d,正试期5 d。结果表明：（1）日粮蛋白质水平对总能摄入量无显著影响（P > 0.05）。（2）从组1到组5粪能逐渐下降,且组3、组4、组5较组1分别降低了10.5%、11.4%、13.7%（P < 0.05）,组5较组2降低了9.5%（P < 0.05）。（3）从组1到组5尿能逐渐增加,除组2与组1、组3间差异不显著（P > 0.05）外,其余组间差异极显著（P < 0.01）。（4）组4和组5总能消化率较组1极显著提高13.2%和11.8%（P < 0.01）,其余各组差异不显著（P > 0.05）。组4总能代谢率较组1极显著提高9.8%（P < 0.01）,其余各组差异不显著（P > 0.05）。对于消化能代谢率,组1和组2差异不显著（P > 0.05）,组3、组4和组5依次显著降低（P < 0.05）。（5）蛋白质采食量与总能消化率、消化能代谢率间的回归方程分别为：Y=0.917X+45.872（R2=0.853）|Y=-0.370X+87.735（R2=0.899）。综上,日粮蛋白质水平与粪能呈负相关,与尿能呈正相关。日粮蛋白质水平为13.6%时,总能消化率和总能代谢率均较8.4%蛋白质水平组极显著提高。总能消化率随蛋白质采食量的提高而线性升高,消化能代谢率则随蛋白质采食量的提高而线性降低。 [关键词] 蛋白质|云南半细毛羊|空怀期|能量代谢     

Association between weight change during initial chemotherapy and clinical outcome in dogs with multicentric lymphoma

The majority of the known prognostic factors in dogs with lymphoma have been evaluated before treatment commences or at the time of diagnosis. Prognostic factors evaluated during the initial phase of treatment are less described but may provide important clinical information. In this retrospective study, 82 canine lymphoma patients were categorized according to the weight change between diagnosis and after 5 weeks of chemotherapy. Dogs that gained greater than 5% or lost greater than 5% of initial body weight were categorized as increased‐ or decreased‐weight groups, respectively. Those in which weight changed less than 5% were categorized as the maintained‐weight group. The median progression‐free survival (PFS) in the increased‐weight group, maintained‐weight group and decreased‐weight group was 226, 256 and 129 days, respectively. The decreased‐weight group had significantly shorter PFS than the increased and maintained groups (P = .023, P = .003, respectively). The median survival time (ST) in the increased‐weight group, maintained‐weight group and decreased‐weight group was 320, 339 and 222 days, respectively. There was no significant difference in ST among the three groups (P = .128). In Cox‐regression results, weight change group and initial body weight were significant risk factors associated to PFS (P = .007, P = .001, respectively) while only patient's initial body weight was a significant risk factor to ST (P = .013). In conclusion, evaluation of initial body weight and weight changes over time can provide valuable information regarding PFS and ST in dogs with multicentric lymphoma.